Literature DB >> 17003321

Reversibility of antipsychotic treatment-related diabetes in patients with schizophrenia: a case series of switching to aripiprazole.

Marc De Hert, Linda Hanssens, Ruud van Winkel, Martien Wampers, Dominique Van Eyck, Andre Scheen, Joseph Peuskens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17003321     DOI： 10.2337/dc-06-1393

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  A case series: evaluation of the metabolic safety of aripiprazole.

Authors:  Marc De Hert; Linda Hanssens; Ruud van Winkel; Martien Wampers; Dominique Van Eyck; Andre Scheen; Joseph Peuskens
Journal:  Schizophr Bull       Date:  2006-08-29       Impact factor: 9.306

2.  Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients.

Authors:  Jimmi Nielsen; Søren Skadhede; Christoph U Correll
Journal:  Neuropsychopharmacology       Date:  2010-06-02       Impact factor: 7.853

3.  Diabetic control and atypical antipsychotics: a case report.

Authors:  Romina Lopez Gaston; Mohan George; Nangai Azhahan
Journal:  J Med Case Rep       Date:  2008-05-14

4.  Association of metabolic syndrome with schizophrenia.

Authors:  Sarita Bajaj; Anurag Varma; Anubha Srivastava; Anand Kumar Verma
Journal:  Indian J Endocrinol Metab       Date:  2013-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.